Fiche publication
Date publication
septembre 2014
Journal
Thrombosis research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GILLERY Philippe
Tous les auteurs :
Kerkeni M, Weiss IS, Jaisson S, Dandana A, Addad F, Gillery P, Hammami M
Lien Pubmed
Résumé
There are limited data regarding the contribution of advanced glycation end products (AGEs) in the presence of coronary artery disease (CAD). We investigated whether serum pentosidine and Nε-carboxymethyllysine (CML) were related to the presence and the severity of CAD.
Mots clés
Aged, Area Under Curve, Arginine, analogs & derivatives, Biomarkers, blood, Case-Control Studies, Coronary Angiography, Coronary Artery Disease, blood, Coronary Stenosis, blood, Cross-Sectional Studies, Female, Glycosylation End Products, Advanced, blood, Humans, Logistic Models, Lysine, analogs & derivatives, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Predictive Value of Tests, ROC Curve, Severity of Illness Index, Tunisia, Up-Regulation
Référence
Thromb. Res.. 2014 Sep;134(3):633-8